Cargando…
Evidence-Based Prescribing of Statins: A Developing World Perspective
Although statins reduce the incidence of cardiovascular disease, they are expensive. How should trial evidence on statins be applied to a resource-poor setting?
Autor principal: | Ong, H. T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1370919/ https://www.ncbi.nlm.nih.gov/pubmed/16478294 http://dx.doi.org/10.1371/journal.pmed.0030050 |
Ejemplares similares
-
Nanotechnology and the Developing World
por: Salamanca-Buentello, Fabio, et al.
Publicado: (2005) -
Regenerative Medicine and the Developing World
por: Greenwood, Heather L, et al.
Publicado: (2006) -
The Co-Management of Tuberculosis and Diabetes: Challenges and Opportunities in the Developing World
por: Sullivan, Timothy, et al.
Publicado: (2012) -
Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
por: Sarpatwari, Ameet, et al.
Publicado: (2015) -
Challenges in Developing Evidence-Based Recommendations Using the GRADE Approach: The Case of Mental, Neurological, and Substance Use Disorders
por: Barbui, Corrado, et al.
Publicado: (2010)